← Eichor
Study identifier: NCT06518746 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation

Condition: Ovarian Cancer  ·  Sponsor: University of Colorado, Denver

PhaseNA
Planned participants50
Who can joinAll sexes, N/A to 30 Years
Healthy volunteersNo

About this study

The "Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation" study is open to a subset of patients with disorders of sex development (DSD) which is associated with the risk of malignancy and a high risk of infertility or sterility. For these patients, experimental gonadal tissue cryopreservation is the only fertility preservation option available. The overall objective of this study is to determine the safety and efficacy of gonadal tissue cryopreservation as a method of preserving fertility and/or restoring hormonal function in patients with gonadal dysgenesis who are at risk of decreased fertility potential or malignancy.

This description comes directly from the study's public registry record.

Talk to the study team

Kristine Corkum, MD  ·  (720) 777-6174  ·  Kristine.Corkum@childrenscolorado.org

Jocelyn Phipers  ·  303-724-7807  ·  Jocelyn.Phipers@cuanschutz.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of ColoradoAurora, Colorado, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06518746